Skip to main content
. Author manuscript; available in PMC: 2014 Jun 15.
Published in final edited form as: Cancer Res. 2013 Oct 11;73(24):7162–7167. doi: 10.1158/0008-5472.CAN-13-2498

Table 2.

TERT promoter mutations

TERT
promoter
mutation
pTa LG
(N =28)
pTa HG
(N =31)
CIS
(N =17)
P
Present (%) 24/28 (86%) 21/31 (68%) 11/17 (65%) 0.18

CIS: Carcinoma in situ; HG: high-grade noninvasive urothelial carcinoma; LG: low-grade noninvasive urothelial carcinoma.